Planned use of long acting reversible postpartum contraception in low-risk women in CenteringPregnancy® group versus individual physician prenatal care by Bakir, Sarah et al.
Proceedings in Obstetrics and Gynecology, 2020;10(1):7 
 
 
Please cite this paper as: Bakir S, Hoff T, Hahn P, Stockdale CK, Hardy-Fairbanks A. Planned use of long acting 
reversible postpartum contraception in low-risk women in CenteringPregnancy® group versus individual physician 
prenatal care. Proc Obstet Gynecol. 2020;10(1):Article 7 [ 11 p.]. Available from: http://ir.uiowa.edu/  Free full text 
article. 
 Corresponding author: Sarah Bakir, University of Iowa Carver College of Medicine, Iowa City, Iowa. Email: sarah-
bakir@uiowa.edu  
Copyright: © 2020 Bakir et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited. 
1 
 
Planned use of long acting reversible postpartum contraception in 
low-risk women in CenteringPregnancy® group versus individual 
physician prenatal care 
Sarah Bakir,1 Tara Hoff, MD,2 Petra Hahn, MD,1 Colleen K. Stockdale, MD MS,2 Abbey 
Hardy-Fairbanks, MD2 
Keywords: CenteringPregnancy®, group prenatal care, contraception, long acting reversible 
contraception, LARC 
Abstract 
Introduction: Education on effective 
contraceptive methods is necessary during the 
prenatal period to help women achieve optimal 
birth spacing. This study identified rates of long-
acting reversible contraception (LARC) uptake in 
women who attended CenteringPregnancy® 
(CP) group prenatal care versus individual 
physician care (IP). 
Methods: Charts for low-risk women who 
participated in group CP or IP prenatal care 
between March 2012 and May 2016 were 
reviewed. Charts of IP subjects were randomly 
selected in each year to achieve a CP:IP ratio of 
at least 1:3. The primary outcome was rate of 
LARC use at discharge and within 8 weeks 
postpartum. Pearson chi-squared test and 
Wilcoxon rank-sum tests were performed, and a 
p-value <0.05 was considered significant.  
Results: 129 women participated in CP care 
and 412 in IP care. CP women were more likely 
nulliparous (91, or 70.5% vs 212, or 51.5%, 
p=0.0001) and more likely to attend at least 15 
prenatal visits (54, or 41.9% vs 62, or 15.1%, 
p<0.0001). LARC use rates at discharge and at 
the postpartum visit were similar (36, or 27.9% 
vs 89, or 21.6%, p=0.142; 39, or 32.2% vs 110, 
or 29.4%, p=0.557). Rates of women using 
effective contraception (LARC and other 
hormonal options, including oral contraceptives 
and Depo Provera) at discharge and at the 
postpartum visit were similar (59, or 45.7% vs 
206, or 50.0%, p=0.177; 72, or 59.5% vs 229, or 
61.2%, p=0.157). IUD use was greater than 
subdermal implant use in both groups (31, or 
24.0% vs 5, or 3.9%; 72, or 17.5% vs 17, or 
4.1%; p=0.081). Rates of routine postpartum 
visit attendance at 6-8 weeks postpartum were 
similar and high in both groups (121, or 93.8% 
vs 374, or 90.8%; adjusted p-value=0.164).  
Conclusion: Although CP subjects had more 
prenatal visits and spent more time with 
providers, there was no difference on uptake of 
LARC or effective contraception at discharge or 
at the postpartum visit when compared to IP 
subjects. 
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Introduction 
Maternal and neonatal mortality rates 
are increasing in the United States more 
than in other countries, despite the US 
spending more money on medical care1. 
In the US, it is estimated that there are 
26.4 maternal deaths per 100,000 live 
births, higher than other developed 
nations2. An estimated one-third of US 
pregnancies occurs less than 18 months 
after a delivery and this increases the 
risk of preterm delivery, low birth weight, 
and maternal/neonatal morbidity3,4. With 
US pregnancies occurring before an 
ideal interpregnancy interval is 
achieved, and with high rates of US 
maternal mortality, effective forms of 
contraception are necessary to help 
women appropriately space 
pregnancies4,5. It is recommended by 
the American College of Obstetricians 
and Gynecologists (ACOG) that 
counseling and education about 
contraceptive options, including 
immediate postpartum long-acting 
reversible contraception (LARC), sub-
dermal implants and intrauterine devices 
(IUD), be done during prenatal care and 
then reinforced postpartum6. Adequate 
and accurate counseling on 
contraceptive options improves method 
satisfaction and acceptance of more 
effective options7. Women prefer 
contraceptive counselling in the mid-
trimester, reporting high levels of 
readiness to make contraceptive plans 
in the prenatal and immediate 
postpartum period8. LARC devices have 
failure rates <1%, but are underutilized 
in the US with only 8-10% of fertile, 
sexually-active women who are at risk of 
unintended pregnancy using these 
effective methods9. Immediate 
postpartum LARC initiated before 
hospital discharge, may optimize the 
success of LARC in reducing undesired 
pregnancy in postpartum women who 
have barriers to returning for visits, with 
an estimated 40-75% of postpartum 
women failing to receive LARC when 
initially intending to do so6. It is unknown 
how many private insurers cover 
immediate LARC after delivery, however 
problematic reimbursement with public 
insurance is well known. Beginning in 
2012, 28 states have enacted coverage 
of postpartum LARC for Medicaid users, 
including the state in which this study 
was conducted10.  
Traditionally, a patient visits obstetric 
care providers individually for 10-15 
minutes up to 15 times throughout the 
pregnancy for general prenatal care. 
Group prenatal care is an alternative 
approach to traditional individual 
prenatal visits. It has been suggested 
that this model of care fosters feelings of 
community and accountability that aids 
providers in counselling on important 
issues in the predelivery period, such as 
breastfeeding benefits, contraception, 
expectations of the labor/delivery 
course, and maternal/neonatal 
nutrition11,12. Additionally, this model of 
care allows for increased time with 
providers compared to individual care. 
This model of care also allots time for 
discussions on the various forms of 
contraception, with discussions of the 
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safety and efficacy of LARC methods. 
CenteringPregnancy® (CP) is a 
standardized method of group prenatal 
care with an emphasis on women as 
active participants in their care. 
Accredited CP programs require 
providers to complete standardized 
training on group care and follow 
specific curriculum. While data exists on 
group prenatal care, studies included 
heterogenous and unstandardized 
group care curricula. One study of CP 
care found subjects to be more 
compliant with postpartum visit 
attendance and were found to have 
higher rates of breastfeeding at hospital 
discharge (6.7% vs 13.9% no-show rate, 
p=0.01; 91.0% vs 69.4%, p<0.001, 
respectively)13. Hale et al, found that 
among 3,637 persons with Medicaid, 
those who participated in CP were more 
likely to access family planning services 
in the first six months postpartum 
(15.1% vs 22.02%; OR, 1.68; 95%CI, 
1.35-2.09), however the type of services 
were not noted14. Two additional 
studies, again among Medicaid patients, 
showed that postpartum contraception 
and LARC use were increased in CP 
patients15,16. No data on other types of 
insurance users are available. 
It is not known if uptake of LARC is 
improved in postpartum women who 
attend CP versus individual physician 
care during the prenatal period in a 
group of subjects with various insurance 
types. We predict that low-risk obstetrics 
patients who attended CP will have 
increased LARC uptake following 
delivery (immediate and delayed) over 
women who participated in traditional 
individual care with general OB 
providers.  
Methods 
A retrospective analysis of low-risk 
women who participated in prenatal care 
with either CenteringPregnancy® (CP) or 
individual physician (IP) care between 
March 2012 and May 2016 at a 
university tertiary care center. The CP 
offered by this institution received grant 
funding to provide training and support 
to healthcare providers in order to offer 
accredited CP at their institution17. The 
CP group of women had already been 
reviewed and data collected from a prior 
study. All women who participated in CP 
care during this time period were 
included, and there were no selection 
criteria for this group. At the tertiary care 
center studied, low-risk women are 
offered CP care as well as general 
individual physician care. Women who 
engaged in CP care were also eligible 
for IP care, and vice versa. The CP 
group received prenatal care from 
certified nurse midwives, and the IP 
group received care by obstetrician 
generalists. Low-risk qualifications 
include women without chronic medical 
conditions that may significantly impact 
pregnancy, including but not limited to, 
chronic hypertension, pre-gestational 
diabetes, gestational diabetes requiring 
medications, significant fetal anomalies, 
twin gestation, renal/cardiac disease, 
and morbid obesity (pre-pregnancy BMI 
>40). This qualification did not change 
throughout the study period. Women 
were excluded from the study if they did 
not meet low-risk qualifications, if the 
pregnancy ended, or if prenatal care 
transferred from low- to high-risk OB 
care prior to the second trimester. For 
women who had multiple pregnancies 
during the study period, only the first 
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was considered. For low-risk women 
who did not participate in CP, care was 
received from an individual obstetric 
care physician. Immediate post-delivery 
LARC was offered starting in 2012 and 
in the state the study was conducted, 
immediate post-delivery LARC was 
unbundled by state insurance in 2014. 
This institution offers immediate post-
delivery LARC to all delivering persons 
regardless of insurance type or mode of 
delivery (vaginal and cesarean). 
Charts of subjects who participated in IP 
physician care during the study time 
were randomly chosen via every 3rd 
chart in alphabetical order with a goal of 
a 1:3 CP to IP ratio and ensuring that 
charts were evenly reviewed per year. A 
1:3 ratio of CP to IP patients was 
desired because this ratio provided 
adequate study power, as the sample of 
CP women was small. Women in IP who 
did not meet low-risk criteria were 
excluded and the next subject was 
reviewed until an eligible subject was 
found. The data on all outcome 
measures recorded were obtained via 
retrospective analysis of electronic 
medical records (EMR) by the same two 
reviewers. The data obtained was 
gathered from notes including routine 
obstetric visit notes, labor and delivery 
summary notes, and demographic 
information recorded in the EMR. 
Approval was obtained from the 
Institutional Review Board of the 
university.  
The primary outcome of the study was 
postpartum LARC at discharge and/or 
within 8 weeks of delivery. LARC 
included intrauterine devices and 
subdermal implants. LARC devices 
placed either immediately following 
delivery prior to discharge, or during the 
routine 6-8week routine postpartum visit 
were included. Separate visits for LARC 
placement outside of the 6-8week 
postpartum period were not considered 
in the primary outcome. Data was 
collected on patients that delivered both 
vaginally and via cesarean section. 
Additionally, demographic information, 
obstetric history, prenatal complications, 
obstetric complications, discharge 
contraception plans, and infant feeding 
method were recorded after 
identification of low-risk women and 
review of subject’s medical record. 
Obstetric history included parity, history 
of preterm delivery, and prior cesarean 
sections. These variables were recorded 
to provide context for generalizability of 
study results and as possible 
confounders. Data were aggregated and 
input into Research Electric Data 
Capture (REDCap) for statistical 
analysis and analysed using Pearson 
chi-square test or Fisher’s exact test for 
nominal categorical variables, Wilcoxon 
rank-sum test for ordinal/continuous 
variables (shown with median), and t-
test for continuous variables (shown 
with mean) using SAS 9.4 (SAS Institute 
Inc, Cary, NC, USA). Multivariate 
analysis was performed for covariates. 




Of the 541 subjects that met criteria for 
review, 129 women participated in CP 
care and 412 women attended IP care. 
The cohorts were similar (Table 1) in 
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terms of age at delivery, median 
gestational age, race (Caucasian), use 
of private insurance, educational level 
above high school, and history of prior 
preterm delivery. CP patients were more 
likely to be nulliparous (70.5% vs 51.5%, 
p-value 0.0001) and attend at least 15 
prenatal visits (41.9% vs 15.1%, p-value 
<0.0001). IP patients were more likely to 
be married/co-habiting (88.8% vs 
81.1%, p-value 0.021) and have a 
history of cesarean section (15.1% vs 
3.1%, p-value 0.0003).   
 
Table 1: Demographic Information 







Age at delivery (years) 
   mean (SD) 







































Education greater than high school 94 (88.7%) 318 (84.8%) 0.351 
Nulliparous 91 (70.5%) 212 (51.5%) 0.0001 
History of Cesarean section 4 (3.1%) 62 (15.1%) 0.0003 
Prior preterm delivery 4 (3.1%) 27 (6.6%) 0.141 
















The statistics relating to LARC use were 
divided into 3 groups (Table 2): subjects 
who received LARC post-delivery prior 
to discharge, subjects discharged with a 
plan to receive LARC at the postpartum 
visit, and subjects who elected LARC at 
the postpartum visit. Multivariate 
analysis controlling for gestational age, 
marital status, nulliparity and history of 
caesarean delivery.  Immediate 
postpartum LARC use was higher in the 
IP group, but not significantly (2.3% vs 
4.6%; adjusted OR 0.32, 95% CI: 0.07-
1.03, adjusted p-value 0.086). LARC as 
planned primary contraception at 
discharge were similar (36, or 27.9% vs 
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89, or 21.6%, adjusted OR 1.32, 95% 
CI: 0.81-2.10, adjusted p-value 
0.255).At the time of the postpartum 
visit, LARC use as primary 
contraception choice was similar 
between cohorts (39, or 32.2% vs 110, 
or 29.4%, adjusted OR 1.04, 95% CI: 
0.65-1.64, adjusted p-value 0.876) 
(Table 2). At discharge and at 6-8weeks 
postpartum, IUD use was greater than 
subdermal implant use in both groups 
(31, or 24.0% vs 5, or 3.9% in CP; 72, or 
17.5% vs 17, or 4.1% in IP; p-value 
0.081). Composite result of effective 
contraceptive options chosen, which 
included LARC, in addition to other 
hormonal options, showed no difference 
between prenatal care types at 
discharge or postpartum visit. The most 
chosen contraceptive method at 
discharge in both groups was no 
contraception/plan to discuss at the 
postpartum visit (34, or 26.4% in the CP 
group; 121, or 29.4% in the IP group, p-
value 0.081).  Rates of routine 
postpartum visit attendance at 6-8weeks 
postpartum were similar and high in 
both groups (121, or 93.8% vs 374, or 
90.8%, adjusted p-value 0.164).   
















(95% CI) p-value 
Immediate post-
partum LARC 3 (2.3%) 19 (4.6%) 
0.49  
(0.14, 1.69) 0.251 
0.32  
(0.07, 1.03) 0.086 
Planned LARC 


































59 (45.7%) 206 (50.0%) 
0.84  
(0.57, 1.25) 0.398 
0.75 
























121 (93.8%) 374 (90.8%) 
1.54 
 (0.70, 3.38) 0.283 
1.85  
(0.82, 4.77) 0.164 
 
Discussion 
The results of this retrospective 
comparison of individual physician care 
versus CenteringPregnancy® in a low-
risk population suggest that there is no 
significant difference in LARC uptake in 
women who participated in CP with 
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CNM providers and in women who 
received prenatal care with an individual 
physician. While CP as an intervention 
alone was not adequate to increase 
LARC uptake, it may increase LARC 
uptake when combined with other 
effective counseling measures. It is 
necessary to educate mothers on the 
significance of spacing pregnancies to 
improve health outcomes, as prior 
studies show deficits in knowledge of 
contraceptive effectiveness among 
women, with 45% of women 
overestimating the effectiveness of the 
most common kinds of contraception19. 
These deficits in knowledge exist in 
postpartum women as well. In one study 
of women who had a preterm delivery, 
90% stated they did not want to become 
pregnant within one year, although 50% 
reported using contraceptive methods of 
low effectiveness20. While contraception 
is traditionally initiated at the postpartum 
visit, previous studies show only 50% of 
women attend21,22. A plan for 
contraceptive method should therefore 
be discussed and in place during the 
prenatal period, since ovulation can 
return rapidly after breastfeeding is 
stopped or decreased23. Thus, it is 
recommended to introduce LARC 
options during the prenatal period to 
educate women, specifically about the 
availability of immediate post-placental 
LARC insertion, as it is associated with 
improved maternal outcome25-26. In this 
study, postpartum visit rates were 
substantially higher in both groups than 
reported in literature. Given that other 
studies have shown higher attendance 
in group prenatal care, perhaps IP care 
high attendance in this cohort explains 
the lack of difference between 
contraceptive use between groups.   
CP and other similar group prenatal 
care models have become increasingly 
popular and allow increased provider 
contact time and a community 
environment to help mothers transition 
into labor and delivery and the 
postpartum period26. CP is one model 
that offers standardized curricula to 
address such topics, and includes 
discussions on postpartum 
contraceptive options12. There was no 
significant difference in use of LARC in 
the two cohorts, as both groups showed 
similar rates of LARC use at discharge 
and at 6-8 weeks postpartum. A 
substantial private insurance rate and 
white race is representative of the area 
in which the study was conducted but 
may limit generalizability to some 
populations.   
A study published in 2019 evaluated the 
effect of insurance-type on uptake of 
LARC at the time of postpartum 
discharge, specifically comparing private 
insurance to Medicaid insurance. This 
study concluded that there were no 
significant differences in postpartum 
LARC uptake between women insured 
by Medicaid vs insured privately when 
adjustments for clinical and 
demographic characteristics were made. 
Additionally, this study concluded that 
prenatal counseling, rather than 
insurance type, was a more important 
determining factor in receiving LARC 
postpartum27. This suggests that while 
there exist financial barriers to care, 
access to maternal education and 
counseling on contraceptive options 
remains a more important factor in 
LARC uptake and effective 
contraception in general. The Iowa 
Medicaid Enterprise (IME) provided 
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Medicaid coverage for LARC devices 
prior to hospital discharge following 
delivery in March 201410,28. This policy 
change was passed in the middle of the 
study period, which was between 2012 
and 2016, however offering immediate 
post-delivery LARC has always been 
offered to all pregnant persons since it 
was started at the institution regardless 
of insurance type. It remains unclear 
whether LARC uptake increased the 
second half of the study period after 
introduction of this policy change, and 
this remains a limitation of the study. 
Overall, recent policy changes in many 
states in the country, including the state 
in which the study was performed, have 
reduced barriers to postpartum LARC 
related to insurance coverage. Despite 
this, at the time this study was 
conducted only one other hospital in the 
state provided immediate post-delivery 
LARC.    
Unlike previous examinations of group 
care that did not have standard 
curriculum or studies of CP that only 
included Medicaid, our study included all 
payors and an accredited CP program. 
The limitations of this study include its 
retrospective design and size. It is 
possible that with more study data and 
power, postpartum LARC use may trend 
more towards significance. The 
exclusion of women who received LARC 
after the 6-8-week postpartum period 
may represent a limitation, given that 
these patients may benefit from LARC 
even if it is not placed in the immediate 
postpartum period. Lastly, there may be 
bias introduced, given that there were 
different types of providers for each 
group. The CP group received care with 
a certified nurse midwife, while the IP 
group received care with an OBGYN 
physician. As each group did not receive 
prenatal care with the same provider, 
there may be bias that limits study 
findings. It is possible that a study 
design comparing CP vs IP with the 
same provider may limit this bias.  
Conclusions 
Despite more contact time and a greater 
number of prenatal visits with providers 
at CenteringPregnancy®, this group of 
women did not show higher rates of 
LARC uptake at discharge and 
postpartum than women who 
participated in traditional, individual 
OB/GYN physician care. Both groups of 
women also had similar rates of high 
postpartum visit attendance. Future 
work is necessary to identify strategies 
to improve LARC availability, given 
known benefits of LARC and recent 
insurance-related policy changes aimed 
at decreasing financial barriers to 
access.   
This project was funded by the University of 
Iowa Carver College of Medicine Summer 
Research Fellowship grant. 
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